DE60124591D1 - Agastache rugosa extrakt mit entzündungshemmender wirkung und antiatherogener wirkung - Google Patents

Agastache rugosa extrakt mit entzündungshemmender wirkung und antiatherogener wirkung

Info

Publication number
DE60124591D1
DE60124591D1 DE60124591T DE60124591T DE60124591D1 DE 60124591 D1 DE60124591 D1 DE 60124591D1 DE 60124591 T DE60124591 T DE 60124591T DE 60124591 T DE60124591 T DE 60124591T DE 60124591 D1 DE60124591 D1 DE 60124591D1
Authority
DE
Germany
Prior art keywords
effect
atherogenic
agastache rugosa
rugosa extract
inflammatory
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60124591T
Other languages
English (en)
Other versions
DE60124591T2 (de
Inventor
Hyeong Kyu Lee
Sei Ryang Oh
Kyung Seop Ahn
Soon Ja Choi
Jung Hee Kim
Goo Taeg Oh
Jung Joo Hong
Seong Kyu Park
Woo Namkung
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Research Institute of Bioscience and Biotechnology KRIBB
Original Assignee
KOREA INST OF BIOSCIENCE AND B
Korea Research Institute of Bioscience and Biotechnology KRIBB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by KOREA INST OF BIOSCIENCE AND B, Korea Research Institute of Bioscience and Biotechnology KRIBB filed Critical KOREA INST OF BIOSCIENCE AND B
Publication of DE60124591D1 publication Critical patent/DE60124591D1/de
Application granted granted Critical
Publication of DE60124591T2 publication Critical patent/DE60124591T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • A61K36/532—Agastache, e.g. giant hyssop
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A23L33/11—Plant sterols or derivatives thereof, e.g. phytosterols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Polymers & Plastics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Diabetes (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Cardiology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60124591T 2001-02-27 2001-12-20 Agastache rugosa extrakt mit entzündungshemmender wirkung und antiatherogener wirkung Expired - Lifetime DE60124591T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
KR2001009977 2001-02-27
KR20010009977 2001-02-27
PCT/KR2001/002224 WO2002074320A1 (en) 2001-02-27 2001-12-20 Agastache rugosa extract and composition containing tilianin isolated and purified from said extract having anti-inflammatory activity and anti-atherogenic activity

Publications (2)

Publication Number Publication Date
DE60124591D1 true DE60124591D1 (de) 2006-12-28
DE60124591T2 DE60124591T2 (de) 2007-09-06

Family

ID=19706307

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60124591T Expired - Lifetime DE60124591T2 (de) 2001-02-27 2001-12-20 Agastache rugosa extrakt mit entzündungshemmender wirkung und antiatherogener wirkung

Country Status (8)

Country Link
US (2) US20040071792A1 (de)
EP (1) EP1363648B8 (de)
JP (1) JP4091436B2 (de)
KR (1) KR100447948B1 (de)
CN (1) CN100376255C (de)
CA (1) CA2439430C (de)
DE (1) DE60124591T2 (de)
WO (1) WO2002074320A1 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060003030A1 (en) * 2004-07-01 2006-01-05 Lin Chun-Ying Essential oils for treating and/ or preventing allergic disease
KR100807645B1 (ko) * 2006-10-17 2008-02-28 주식회사 유니젠 위장질환 치료 및 예방용 조성물 및 그의 제조방법
KR100851489B1 (ko) * 2006-11-30 2008-08-08 (주)아모레퍼시픽 틸리아닌( ｔｉｌｉａｎｉｎ) 또는아카세틴(ａｃａｃｅｔｉｎ)을 유효성분으로 함유하는화장료 조성물
DE202008011721U1 (de) * 2008-09-03 2008-12-24 American Phoenix Biotech Inc., Hacienda Heights Pflanzliche Zusammensetzung zur Behandlung von Krebs
KR101540310B1 (ko) * 2013-08-07 2015-07-30 건국대학교 산학협력단 방아풀 추출물을 함유하는 신경 염증 예방 및 치료용 조성물, 그리고 방아풀 추출물 추출 방법
EP3243902A4 (de) * 2015-01-06 2018-05-30 Luterion Co., Ltd. Luterion und trennung und kultivierungsverfahren dafür
PL412214A1 (pl) 2015-05-04 2016-11-07 Biovico Spółka Z Ograniczoną Odpowiedzialnością Kompozycja roślinna o właściwościach przeciwzapalnych, przeciwalergicznych i/lub przeciwastmatycznych oraz jej zastosowanie
KR102049875B1 (ko) 2018-06-29 2019-11-28 충북대학교 산학협력단 에키나세아 배양근 유래 신규 화합물 및 이의 항염증 용도
CN111171094B (zh) * 2018-11-13 2023-06-16 上海医药工业研究院有限公司 一种香清兰苷中间体及其制备方法和应用
KR102339923B1 (ko) * 2019-11-12 2021-12-20 한국한의학연구원 혈행 개선용 식치제호탕 조성물
KR102300732B1 (ko) * 2020-11-11 2021-09-14 주식회사 제이에스무역 난황유 및 배초향 줄기세포를 함유하는 항산화, 미백, 항주름 또는 항염증용 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3831196A1 (de) * 1988-09-14 1990-03-22 Bosch Gmbh Robert Elektromagnetisch betaetigbares ventil
CN1060772A (zh) * 1991-10-30 1992-05-06 阳山县食品厂 一种藿香姜计陈皮的生产工艺
CN1057447C (zh) * 1993-01-22 2000-10-18 马军营 一种治疗小儿腹泻的口服液
CN1117388A (zh) * 1994-08-24 1996-02-28 东营市面粉厂 复方柴胡擦剂
JPH08176002A (ja) * 1994-12-27 1996-07-09 Kao Corp 細胞接着抑制剤
KR970007366A (ko) * 1995-07-31 1997-02-21 고제섭 압축단자 접촉저항 측정장치 및 그 방법
CN1151881A (zh) * 1995-12-01 1997-06-18 陶周行 一种阴道冲洗保留剂及其制备工艺与使用方法
JP4424628B2 (ja) * 1996-09-27 2010-03-03 ネイチャーテクノロジー株式会社 フリーラジカルを消去するための抗酸化性組成物、その組成物を含む医薬組成物およびその製造方法
US5776462A (en) * 1996-12-10 1998-07-07 Sage R&D, A Partnership Pogostemon cablin extract for inhibiting H. influenzae adhesion and treating otitis media or sore throat
KR100232053B1 (ko) * 1997-04-22 1999-12-01 김동태 DPPH(1,1-diphenyl-2-picrylhydrazyl)를 이용한 항산화물질의 분석방법
JP4231559B2 (ja) * 1997-04-23 2009-03-04 オリザ油化株式会社 リポキシゲナーゼ阻害剤
KR100215400B1 (ko) * 1997-05-27 1999-08-16 김진수 건강보조식품용 유중수적형 영양음료 및 그 제조방법
KR100309071B1 (ko) * 1998-09-02 2001-12-17 성재갑 콜라겐합성촉진제를함유한피부용조성물
KR100341798B1 (ko) * 1999-08-04 2002-06-26 대한민국 (관리청:특허청장, 승계청:농촌진흥청장) 방아잎으로부터 로즈마린산을 분리하는 방법
AU2446801A (en) * 1999-12-23 2001-07-03 Ancile Pharmaceuticals, Inc. Treatment for inflammatory bowel disease (ibd) and related conditions
KR100376306B1 (ko) * 2000-08-07 2003-03-17 한완석 혈액순환 촉진용 건강식품 조성물
CN1126453C (zh) * 2000-08-09 2003-11-05 郭兴华 天然抗菌组合物及其应用
CN1282537A (zh) * 2000-08-22 2001-02-07 张益� 一种藿香饮料

Also Published As

Publication number Publication date
EP1363648A4 (de) 2005-02-09
EP1363648A1 (de) 2003-11-26
US20080081081A1 (en) 2008-04-03
CA2439430C (en) 2010-06-22
JP4091436B2 (ja) 2008-05-28
EP1363648B1 (de) 2006-11-15
KR20020070062A (ko) 2002-09-05
CN100376255C (zh) 2008-03-26
EP1363648B8 (de) 2007-04-25
CN1518454A (zh) 2004-08-04
US20040071792A1 (en) 2004-04-15
CA2439430A1 (en) 2002-09-26
DE60124591T2 (de) 2007-09-06
KR100447948B1 (ko) 2004-09-08
JP2004521933A (ja) 2004-07-22
US7534456B2 (en) 2009-05-19
WO2002074320A1 (en) 2002-09-26

Similar Documents

Publication Publication Date Title
DE60123274D1 (de) Pyrrolcarboxamide und pyrrolcarbothioamide und deren agrochemische verwendungen
DE60030541D1 (de) Leuchte und leuchttafeln
DE50112013D1 (de) Deodorantien und antiperspirantien
DE69919156D1 (de) Oxyiminoalkansäure derivate mit hypoglykämischer und hypolipidemischer wirkung
DE50102799D1 (de) Beleuchtungs- und anzeigevorrichtung
DE29810742U1 (de) Einstellbare Beleuchtungs- und Rückholvorrichtung
DE60012213D1 (de) Fünfgliedrige n-heterocyclen mit hypoglykämischer und hypolipidemischer wirkung
DE69703207T2 (de) Verbindungen mit entzündungshemmender und immunsuppressiver wirkung
DE69831233D1 (de) Barbitursaure derivaten mit antimetastatischer und antitumorischer wirkung
DE60134026D1 (de) Bildanzeigeelement und bildanzeigeeinrichtung
DE60029251D1 (de) Mpeg-ummultiplexer mit mehreren eingängen und mehreren ausgängen
DE69924155D1 (de) Fluoren-copolymere und daraus hergestellte vorrichtungen
DE60014893D1 (de) Pyrazolobenzodiazepine mit cdk2 hemmender wirkung
DE60120802D1 (de) Lagervorrichtung mit modularer und nachgiebiger Dichtung
DE60115126D1 (de) Funduskamera mit sichtbarer und unsichtbarer Beleuchtung
DE60124591D1 (de) Agastache rugosa extrakt mit entzündungshemmender wirkung und antiatherogener wirkung
DE60208729D1 (de) Selbstausrichtendes und rastendes Befestigungselement
DE50104294D1 (de) Kosmetische zubereitungen mit waltheria indica extrakten und ferulasäure
DE60132500D1 (de) Hocheffizientes heizelement und abmantelungsvorrichtung
DE60010280D1 (de) Substituierte pyridazinen und kondensierte pyridazinen mit angiogenesis-inhibierender wirkung
DE60232699D1 (de) FET Strukturen mit symmetrischen und/oder verteilten vorwärtsgekoppelten Kondensatorverbindungen
DE60203475D1 (de) Drosselklappe und Drossel
DE50006911D1 (de) Verriegelungsnagel und zielgerät
DE60117096D1 (de) Dihydroindol- und tetrahydrochinolinderivate
DE60142886D1 (de) Anzeigeelement und anzeigevorrichtung

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIO, KR

8364 No opposition during term of opposition